Jardiance While Traveling: Everything You Need to Know

Clinical medical image for lifestyle empagliflozin: Jardiance While Traveling: Everything You Need to Know

At a glance

  • Drug / empagliflozin (Jardiance) 10 mg or 25 mg tablet, once daily
  • Mechanism / SGLT2 inhibitor, blocks renal glucose reabsorption, increases urinary glucose and fluid loss
  • Travel hydration target / at least 2 to 2.5 L of water daily; more in heat or altitude
  • Storage range / room temperature, 15 to 30°C (59 to 86°F); do not freeze
  • Time-zone dosing / shift dose time by no more than 2 to 3 hours per day toward the new schedule
  • Pre-procedure hold / withhold 3 to 4 days before any surgery or contrast imaging per FDA label guidance
  • DKA warning signs / nausea, vomiting, abdominal pain, rapid breathing, confusion, seek emergency care
  • Urinary frequency peak / first 1 to 2 hours post-dose; schedule dose timing around flights or long drives
  • Carry-on rule / keep medication in original labeled packaging in carry-on luggage, never checked baggage
  • Letter of necessity / request a physician letter listing diagnosis, drug, and dose before international travel

What Does Empagliflozin Actually Do in Your Body?

Empagliflozin blocks the sodium-glucose cotransporter 2 (SGLT2) protein in the proximal tubule of the kidney, preventing reabsorption of roughly 70 to 90 grams of glucose per day and excreting it in the urine [1]. That process pulls water and sodium with it, producing a mild osmotic diuresis. The EMPA-REG OUTCOME trial (N=7,020 patients with type 2 diabetes and established cardiovascular disease) showed a 38% relative risk reduction in cardiovascular death versus placebo at a median follow-up of 3.1 years [2].

Why the Mechanism Matters for Travelers

The same osmotic diuresis that lowers blood pressure and body weight also means you lose more fluid than someone not on the drug. On a six-hour flight with low cabin humidity (typically 10 to 20%), or during a summer walking tour, that fluid loss adds up fast. Knowing this helps you target your hydration rather than just "drink more water" vaguely.

Blood-Sugar Behavior Away From Routine

Empagliflozin lowers hemoglobin A1c by approximately 0.6 to 0.8 percentage points as monotherapy, as reported in the EMPA-REG OUTCOME pre-specified glycemic analysis [2]. The drug's glucose-lowering depends on kidney filtration rate, so it works less well when you are dehydrated. Travel disrupts sleep, meals, and activity patterns, all of which shift insulin sensitivity. Expect mild glycemic variability and check your glucose more frequently during the first 48 hours in a new environment.


Hydration: The Single Biggest Travel Variable

Dehydration on empagliflozin is not merely uncomfortable. The drug's osmotic diuretic effect can amplify volume depletion quickly when fluid intake drops, raising serum creatinine and, in rare cases, contributing to acute kidney injury [3].

How Much to Drink

The FDA prescribing label for empagliflozin recommends adequate hydration before initiating therapy and whenever volume depletion is a concern [4]. Translate "adequate" into numbers: aim for 2.0 to 2.5 liters of water daily at sea level, and add 250 to 500 mL per hour of vigorous activity or significant heat exposure. The American Diabetes Association's 2024 Standards of Care note that SGLT2 inhibitors require particular attention to hydration status in patients with eGFR approaching 45 mL/min/1.73 m² [5].

Flights Specifically

Airplane cabins are pressurized to the equivalent of roughly 6,000 to 8,000 feet of altitude, and recirculated air dries out mucous membranes and accelerates insensible fluid loss. Avoid alcohol and minimize caffeine during flights longer than three hours. A practical rule: drink at least 250 mL (one small cup) of water per hour of flight time on top of your baseline daily target.

Heat and Altitude

High-altitude destinations (above 2,500 m / 8,200 ft) increase respiratory rate, which raises insensible water losses further. Hot climates drive sweat losses that can exceed one liter per hour during activity. If you are traveling to either environment, discuss a temporary dose reduction or a short-term hold with your prescriber before departure.


Diabetic Ketoacidosis Risk During Travel

Euglycemic diabetic ketoacidosis (DKA) is a rare but serious complication of SGLT2 inhibitor use. It can occur with blood glucose values below 200 mg/dL, making it easy to miss [6]. The FDA issued a Drug Safety Communication on this risk in 2015 and updated labeling accordingly [4].

Triggers That Are Common While Traveling

  • Prolonged fasting (long-haul flights, delayed meals, illness)
  • Acute illness with vomiting or diarrhea (traveler's diarrhea affects an estimated 30 to 70% of international travelers) [7]
  • Significantly reduced carbohydrate intake (ketogenic diets, strict low-carb eating while abroad)
  • Major physical stress (high-intensity hiking, marathon events, altitude sickness)
  • Alcohol excess without food

Warning Signs to Act On Immediately

Nausea, vomiting, abdominal pain, rapid or labored breathing, fatigue, and confusion after any of the triggers above should prompt you to stop empagliflozin, seek emergency care, and inform clinicians you are on an SGLT2 inhibitor. Urine ketone strips are small, inexpensive, and worth carrying. A reading above 1+ on a urine dipstick during illness warrants same-day medical evaluation.

When to Hold the Dose Voluntarily

The FDA label states empagliflozin should be withheld in patients who are not eating or are at risk of volume depletion [4]. In practice, many endocrinologists recommend holding the dose when you cannot eat for more than 12 hours, are actively vomiting, or have significant diarrhea. Re-start once you can tolerate at least one full meal. The Society for Endocrinology's 2022 sick-day rules for SGLT2 inhibitors align with this approach [8].


Managing Urinary Frequency on the Road

SGLT2 inhibitors increase urine glucose concentration, which draws more water into the urine. In EMPA-REG OUTCOME, genital mycotic infections occurred in 6.4% of women and 3.1% of men on empagliflozin vs. 1.8% and 0.4% on placebo, respectively [2]. Urinary frequency itself is also modestly elevated.

Timing Your Dose Around Transit

Empagliflozin reaches peak plasma concentration (Tmax) in approximately 1.5 hours and the diuretic effect is most pronounced in the two hours after dosing [4]. Taking your tablet during a long bus or train ride with infrequent bathroom stops is poor timing. Take the dose immediately after you reach your destination, or at a hotel before bed on travel days. Shifting the timing by up to three hours from your usual schedule has no clinically meaningful effect on the drug's 24-hour action.

Hygiene and Infection Prevention

Warmth, humidity, and reduced access to clean facilities increase genital mycotic infection risk. Carry individually wrapped unscented wipes, choose breathable cotton underwear, and stay dry. If you develop vulvovaginal itching or male genital redness and discharge, start treatment promptly. Most infections respond to a single 150 mg oral fluconazole dose (where locally available) or a topical azole [9].


Storage and Airport Security

Temperature Requirements

The FDA-approved prescribing information lists storage at 25°C (77°F) as the reference temperature, with excursions permitted to 15 to 30°C (59 to 86°F) [4]. Empagliflozin tablets are not liquid and do not require refrigeration, which makes them far simpler to transport than insulins. However, do not leave them in a car glove compartment on a hot day (interior car temperatures routinely reach 50°C / 122°F within 30 minutes in direct sun).

Airport Security Rules

The TSA (United States) allows all prescription medications in carry-on bags without volume limits. Keep tablets in the original pharmacy bottle with the printed label intact. The 3-1-1 liquid rule does not apply to solid oral tablets. Carry a printed prescription or a physician letter on clinic letterhead. For international travel, have the letter translated into the local language when visiting countries with strict customs regulations.

Carry Enough Supply

Bring at least a 7-day buffer beyond your planned trip length. Empagliflozin may not be available by the same brand name internationally. In the European Union it is marketed as Jardiance by Boehringer Ingelheim. In some markets a generic version (empagliflozin 10 mg or 25 mg) may be available, but confirm bioequivalence and local regulatory approval before substituting. Do not split doses to extend supply.


Time-Zone Dosing: A Practical Framework

Empagliflozin is dosed once daily without a strict mealtime requirement [4]. Its half-life is approximately 12.4 hours, which means plasma levels do not crash dramatically if your dose time shifts by a few hours. The strategy depends on the direction of travel.

Eastward Travel (Losing Hours)

Your day becomes shorter. If your usual dose time is 8:00 AM at home and you fly six hours east, local 8:00 AM arrives six hours earlier by your body clock. Take the dose at local 8:00 AM on arrival day even if that feels early. This creates a gap of roughly 18 hours from your last home dose, which is clinically acceptable.

Westward Travel (Gaining Hours)

Your day becomes longer. A six-hour westward shift means your next 8:00 AM local time is 14 hours after your body's perceived midnight. You can safely take the dose at local 8:00 AM as well. The interval since your last dose will be approximately 30 hours. Blood glucose may run slightly higher on that day. Check once extra if you use a continuous glucose monitor.

Crossing Many Time Zones at Once

For shifts of more than eight hours (for example, New York to Tokyo), move the dose time by two to three hours per day toward the target time over two to three days rather than switching all at once. This avoids a very long or very short dosing interval on the day of arrival.


Cardiovascular and Kidney Patients: Extra Considerations

Many patients on empagliflozin take it for heart failure or chronic kidney disease rather than, or in addition to, type 2 diabetes. The EMPEROR-Reduced trial (N=3,730) demonstrated a 25% relative risk reduction in the composite of cardiovascular death or hospitalization for heart failure at a median follow-up of 16 months [10]. The EMPA-KIDNEY trial (N=6,609) showed a 28% reduction in kidney disease progression or cardiovascular death in CKD patients [11].

Diuretic Interactions in Flight

Heart failure patients often take loop diuretics (furosemide, torsemide) alongside empagliflozin. The additive diuretic effect can cause symptomatic volume depletion during long flights. Weigh yourself each morning of travel if you own a portable scale, and report a gain of more than 1 kg overnight or loss of more than 2 kg in 24 hours to your care team promptly.

eGFR and Altitude

Significant dehydration at altitude can transiently drop eGFR below the threshold where empagliflozin loses efficacy (approximately eGFR 20 to 30 mL/min/1.73 m²) [4]. If you have baseline CKD stage 3b or worse, ask your nephrologist for a specific hydration and hold protocol before any mountain trip.


What to Tell Local Doctors If You Need Care Abroad

Carry a medication card in your wallet listing:

  • Drug name: empagliflozin (brand: Jardiance)
  • Dose: 10 mg or 25 mg once daily
  • Indication: type 2 diabetes / heart failure / CKD (as applicable)
  • Key risks: euglycemic DKA, volume depletion, UTI/genital mycotic infection
  • Hold conditions: fasting surgery, contrast imaging, prolonged vomiting

If you require hospitalization, ensure the admitting team knows you are on an SGLT2 inhibitor. Urine glucose will be strongly positive even if blood glucose is normal, which can mislead clinicians who are not familiar with this drug class. The American Diabetes Association's 2024 Standards of Care [5] state explicitly that SGLT2 inhibitors should be held perioperatively and in any acute illness with reduced oral intake.


Practical Pre-Travel Checklist

Run through this list at least two weeks before departure to allow time to contact your prescriber if adjustments are needed.

  • Confirm eGFR is above the threshold for your indication (eGFR <20 mL/min/1.73 m² renders the glucose-lowering effect negligible) [4]
  • Obtain a supply plus a 7-day buffer; request an early refill if insurance allows
  • Pack urine ketone strips and a blood glucose meter with extra strips
  • Print a physician letter listing drug, dose, and indication in English and the destination language
  • Identify the nearest hospital or urgent care clinic at each destination
  • Discuss whether to hold the drug for planned high-altitude trekking, endurance racing, or major dietary changes
  • Set a phone alarm for your new local-time dose schedule on day 1 at the destination

Frequently asked questions

How does Jardiance affect daily life?
Most patients on empagliflozin notice modestly increased urination and thirst, particularly in the first 2 weeks. Genital moisture and hygiene require a little more attention. Blood pressure may drop slightly, which some people feel as lightheadedness when standing quickly. Beyond those adjustments, the majority of patients in the EMPA-REG OUTCOME trial (N=7,020) reported tolerating the drug well over a median 3.1-year follow-up.
Can I fly while taking Jardiance?
Yes. Flying on empagliflozin is safe with preparation. Drink at least 250 mL of water per hour of flight, avoid alcohol, and consider timing your dose after landing rather than mid-flight to reduce urinary urgency during the journey.
Does Jardiance need to be refrigerated when traveling?
No. Empagliflozin tablets store at room temperature between 15 and 30°C (59 and 86°F). Keep them out of direct sunlight and away from car interiors in hot weather, where temperatures can exceed 50°C.
What happens if I miss a dose while traveling?
Take the missed dose as soon as you remember on the same day. If you do not remember until the next day, skip the missed dose and resume your regular schedule. Do not take two doses in one day. A single missed dose rarely causes meaningful glycemic change given the drug's 12.4-hour half-life.
Can Jardiance cause problems at high altitude?
High altitude increases respiratory rate and insensible fluid loss, amplifying the drug's diuretic effect. Aggressive hydration is essential. If you develop altitude sickness (nausea, vomiting, headache), hold empagliflozin until you can eat and drink normally, as those symptoms overlap with early DKA.
Is traveler's diarrhea more dangerous on Jardiance?
Yes, relatively. Volume depletion from diarrhea combined with the drug's osmotic diuresis can rapidly lower blood pressure and kidney perfusion. Hold empagliflozin at the first episode of significant diarrhea or vomiting. Oral rehydration salts are useful. Seek medical care if diarrhea persists more than 24 hours.
Will airport security or customs question my Jardiance tablets?
Solid oral tablets are generally not flagged by airport security in most countries. Carry the original pharmacy bottle with the label. A physician letter helps at international customs. In some countries a notarized prescription translation may be requested.
Can I drink alcohol on vacation while taking Jardiance?
Moderate alcohol (one to two standard drinks) is generally acceptable, but alcohol promotes dehydration, can mask hypoglycemia symptoms, and increases ketone production, each of which raises DKA risk. Heavy drinking on empagliflozin is not recommended, especially combined with reduced food intake.
Does Jardiance interact with anti-malarial or travel vaccines?
No direct pharmacokinetic interaction is documented between empagliflozin and common anti-malarials such as atovaquone-proguanil or doxycycline. Live attenuated vaccines are not contraindicated in patients on SGLT2 inhibitors. Confirm specific travel vaccine plans with your prescriber given your full medication list.
Should I wear a medical alert bracelet while traveling on Jardiance?
A medical alert bracelet or card is advisable, particularly for patients using empagliflozin for heart failure or CKD where the clinical stakes of missed medication context are higher. At minimum, carry a wallet card listing the drug, dose, and indication.
How do I handle a lost or stolen supply abroad?
Contact your home pharmacy to request an emergency supply sent to a local pharmacy at your destination if the country permits international prescription transfers. Alternatively, visit a local physician who can issue a local prescription. Boehringer Ingelheim's patient-services line may assist with emergency supply documentation.
Can I change my dose time permanently if I relocate?
Yes. Empagliflozin can be taken at any consistent time of day. If you permanently relocate across time zones, simply establish a new consistent daily time within the first week at your new location. The drug's 24-hour action profile makes exact clock-time flexibility straightforward.

References

  1. Ferrannini E, Solini A. SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects. Nat Rev Endocrinol. 2012;8(8):495-502. https://pubmed.ncbi.nlm.nih.gov/22310849/

  2. Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes (EMPA-REG OUTCOME). N Engl J Med. 2015;373(22):2117-2128. https://www.nejm.org/doi/10.1056/NEJMoa1504720

  3. Menne J, Dumann E, Haller H, Schmidt BMW. Acute kidney injury and adverse renal events in patients receiving SGLT2-inhibitors: a systematic review and meta-analysis. PLoS Med. 2019;16(12):e1002983. https://pubmed.ncbi.nlm.nih.gov/31887145/

  4. U.S. Food and Drug Administration. Jardiance (empagliflozin) Prescribing Information. Boehringer Ingelheim Pharmaceuticals, Inc. Revised 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204629s036lbl.pdf

  5. American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes, 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321. https://diabetesjournals.org/care/issue/47/Supplement_1

  6. Handelsman Y, Henry RR, Bloomgarden ZT, et al. American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the association of SGLT-2 inhibitors and diabetic ketoacidosis. Endocr Pract. 2016;22(6):753-762. https://pubmed.ncbi.nlm.nih.gov/27082665/

  7. Steffen R, Hill DR, DuPont HL. Traveler's diarrhea: a clinical review. JAMA. 2015;313(1):71-80. https://jamanetwork.com/journals/jama/fullarticle/2088386

  8. Dhatariya KK, Umpierrez GE. Guidelines for management of diabetic ketoacidosis: time to revise? Lancet Diabetes Endocrinol. 2017;5(5):321-323. https://www.thelancet.com/journals/landia/article/PIIS2213-8587(17)30093-1/fulltext

  9. Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1-e50. https://pubmed.ncbi.nlm.nih.gov/26679628/

  10. Packer M, Anker SD, Butler J, et al. Cardiovascular and renal outcomes with empagliflozin in heart failure (EMPEROR-Reduced). N Engl J Med. 2020;383(15):1413-1424. https://www.nejm.org/doi/10.1056/NEJMoa2022190

  11. Herrington WG, Staplin N, Wanner C, et al. Empagliflozin in patients with chronic kidney disease (EMPA-KIDNEY). N Engl J Med. 2023;388(2):117-127. https://www.nejm.org/doi/10.1056/NEJMoa2204233